Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab extension trial in adults with active rheumatoid arthritis previously treated in Hx-CD20-403
2007-004878-31Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ofatumumab in rheumatoid arthritis (RA), sponsored by GSK. Primary endpoint: Time to treatment withdrawal. Started Oct 2007; status: completed.
02
Drugs
ofatumumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-004878-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004878-31.